BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES - Summary of revenues disaggregated by our business operations and timing of revenue recognition (Details) - USD ($)	3 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Disaggregation of Revenue [Line Items]
Total	$ 1,616,141	$ 633,519
Research and development services (over-time)
Disaggregation of Revenue [Line Items]
Total	263,713	366,834
Clinical laboratory testing services (point-in-time)
Disaggregation of Revenue [Line Items]
Total	772,770	0
Supply chain
Disaggregation of Revenue [Line Items]
Total	32,942	18,674
Asset marking
Disaggregation of Revenue [Line Items]
Total	151,758	108,572
Large scale DNA production
Disaggregation of Revenue [Line Items]
Total	0	139,439
Diagnostic kits
Disaggregation of Revenue [Line Items]
Total	$ 394,958	$ 0